Genomic Classification of Serous Ovarian Cancer with Adjacent Borderline Differentiates RAS Pathway and <i>TP53</i> -Mutant Tumors and Identifies <i>NRAS</i> as an Oncogenic Driver
Catherine Emmanuel(Peter MacCallum Cancer Centre), Anna DeFazio(The University of Sydney), David D.L. Bowtell(The University of Melbourne), Michael S. Anglesio(University of British Columbia), Ian Campbell(The University of Sydney), Joshy George(Jackson Laboratory), Gerard Wain(Westmead Hospital), Catherine J. Kennedy(The University of Sydney), Christine L. Clarke(Memorial University of Newfoundland), Stephen Q. Wong(Peter MacCallum Cancer Centre), Sián Fereday(Peter MacCallum Cancer Centre), Laura Galletta(Peter MacCallum Cancer Centre), Yoke-Eng Chiew(The University of Sydney), Hongdo Do(Peter MacCallum Cancer Centre), Paul R. Harnett(The University of Sydney), Alison H. Brand(The University of Sydney), Rosemary L. Balleine(The University of Sydney), Dariush Etemadmoghadam(Peter MacCallum Cancer Centre), Sally M. Hunter(Peter MacCallum Cancer Centre), Laura E. MacConaill(Brigham and Women's Hospital), Raghwa Sharma(Royal Prince Alfred Hospital), Peter Russell(The University of Sydney), Russell Hogg(Westmead Hospital), Emanuele Palescandolo(Harvard University), Jillian A. Hung(Millennium Institute), Alexander Dobrovic(The University of Melbourne)
Cited by 119
Related Papers
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
|Nature|2012|8.5k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k
<i>ARID1A</i> Mutations in Endometriosis-Associated Ovarian Carcinomas
|New England Journal of Medicine|2010|1.7k
Whole–genome characterization of chemoresistant ovarian cancer
|Nature|2015|1.7k
Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
|Clinical Cancer Research|2008|1.5k